This page is part of the Logica COVID-19 FHIR Profile Library IG (v1.0.0: Informative - Informative) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

ValueSet: Detected, Not Detected, Inconclusive Value Set

Official URL: http://hl7.org/fhir/us/covid19library/ValueSet/covid19-det-notdet-eq-inc-vs				Version: 1.0.0
Active as of 2022-07-25				Computable Name: DetNotDetEqInVS
Copyright/Legal: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement

A set of SNOMED codes representing the result of a test as detected, not detected, equivalent, or inconclusive.

References

• Human coronavirus 229E+HKU1+OC43+NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
• Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection
• Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
• Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
• Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection
• SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum, Plasma, or Blood by Rapid imunoassay
• SARS-CoV-2 (COVID19) E gene [Presence] in Serum or Plasma by NAA with probe detection
• SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection
• SARS-CoV-2 (COVID19) N gene [Presence] in Serum or Plasma by NAA with probe detection
• SARS-CoV-2 (COVID19) [Presence] in Unspecified specimen by Organism specific culture
• Sars-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with probe detection
• SARS-CoV-2 (COVID19) S gene [Presence] in Serum or Plasma by NAA with probe detection
• SARS-CoV + SARS-Cov-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
• SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
• SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
• SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
• SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
• SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
• SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
• SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
• SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
• SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing

Logical Definition (CLD)

 

Expansion

---

Explanation of the columns that may appear on this page:

Level	A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System	The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code	The code (used as the code in the resource instance)
Display	The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition	An explanation of the meaning of the concept
Comments	Additional notes about how to use the code